FSME IMMUN 0,25 ml za otroke suspenzija za injiciranje v napolnjeni injekcijski brizgi Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

fsme immun 0,25 ml za otroke suspenzija za injiciranje v napolnjeni injekcijski brizgi

pfizer luxembourg sarl - virus klopnega meningoencefalitisa, inaktivirani - suspenzija za injiciranje - virus klopnega meningoencefalitisa, inaktivirani 1,2 µg / 0,25 ml - cepivo proti klopnemu meningoencefalitisu, s celimi virusi, inaktivirano

Foclivia Evropska unija - slovenščina - EMA (European Medicines Agency)

foclivia

seqirus s.r.l.  - površinski antigeni virusa influence, inaktivirani: a / viet nam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - cepiva proti gripi - preprečevanje gripe v uradno prijavljeni pandemični situaciji. pandemije gripe cepiva je treba uporabljati v skladu z uradnimi smernice.

Celdoxome pegylated liposomal Evropska unija - slovenščina - EMA (European Medicines Agency)

celdoxome pegylated liposomal

yes pharmaceutical development services gmbh - doksorubicinijev klorid - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antineoplastična sredstva - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).

PAROFOR 140 Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

parofor 140

huvepharma nv uitbreidingstraat 80 2600 antwerpen belgija izdelovalec -

Garamycin 80 mg/ml raztopina za injiciranje/infundiranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

garamycin 80 mg/ml raztopina za injiciranje/infundiranje

krka, d.d., novo mesto - gentamicin - raztopina za injiciranje/infundiranje - gentamicin 120 mg / 1,5 ml - gentamicin

DULTAVAX suspenzija za injiciranje v napolnjeni injekcijski brizgi Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

dultavax suspenzija za injiciranje v napolnjeni injekcijski brizgi

sanofi pasteur - davični toksoid; tetanusni toksoid; poliovirus tipa 1 (sev mahoney), inaktivirani; poliovirus tipa 2 (sev mef-1), inaktivirani; poliovirus tipa 3 (sev saukett), inaktivirani - suspenzija za injiciranje v napolnjeni injekcijski brizgi - davični toksoid 2 i.e. / 1 ml  tetanusni toksoid20 i.e. / 1 ml  poliovirus tipa 1 (sev mahoney), inaktivirani40 i.e. / 1 ml  poliovirus tipa 2 (sev mef-1), inaktivirani8 i.e. / 1 ml  poliovirus tipa 3 (sev saukett), inaktivirani32 i.e. / 1 ml; tetanusni toksoid 20 i.e. / 1 ml  poliovirus tipa 1 (sev mahoney), inaktivirani40 i.e. / 1 ml  poliovirus tipa 2 (sev mef-1), inaktivirani8 i.e. / 1 ml  poliovirus tipa 3 (sev saukett), inaktivirani32 i.e. / 1 ml; poliovirus tipa 1 (sev mahoney), inaktivirani 40 i.e. / 1 ml  poliovirus tipa 2 (sev mef-1), inaktivirani8 i.e. / 1 ml  poliovirus tipa 3 (sev saukett), inaktivirani32 i.e. / 1 ml; poliovirus tipa 2 (sev mef-1), inaktivirani 8 i.e. / 1 ml  poliovirus tipa 3 (sev saukett), inaktivirani32 i.e. / 1 ml; poliovirus tipa 3 (sev saukett), inaktivirani 32 i.e. / 1 ml - mešano cepivo proti davici, otroški paralizi in tetanusu